Download PDF
Z Gastroenterol 2024; 62(07): 1088-1089
DOI: 10.1055/a-2240-1827
Editorial

Editorial zur Aktualisierung der S2k-Leitlinie Gastrointestinale Infektionen v2.0

Carolin Friederike Manthey
1   Gemeinschaftspraxis Innere Medizin (GIM), Witten, Germany
,
Marylyn M. Addo
2   I. Medizinische Klinik und Poliklinik Gastroenterologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
,
Andreas Stallmach
3   Gastroenterologie, Hepatologie und Infektiologie, Friedrich Schiller Universität, Jena, Germany
,
Ansgar W. Lohse
2   I. Medizinische Klinik und Poliklinik Gastroenterologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Schlüsselwörter

Gastroenteritis - GI-Infektion - Diarrhoe - Campylobacter - Salmonellen - Clostridioides difficile - Flüssigkeitssubstitution - Azithromycin - Fidaxomicin


Publication History

Received: 05 January 2024

Accepted: 08 January 2024

Article published online:
08 July 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Robert Koch Institut (RKI). Infektionsepidemiologisches Jahrbuch für 2020. 2021
    PubMedSearch in Google Scholar
  • 2 Lammert F, Lynen Jansen P, Lerch MM. Weißbuch Gastroenterologie 2020/2021: De Gruyter. 2019
    PubMedSearch in Google Scholar
  • 3 Wilking H, Spitznagel H, Werber D. et al. Acute gastrointestinal illness in adults in Germany: a population-based telephone survey. Epidemiol Infect 2013; 141: 2365-2375
    CrossrefPubMedSearch in Google Scholar
  • 4 Lübbert C. Gastrointestinale Infektionen: Steigende Hospitalisierungs- und Mortalitätsraten. Deutsches Aerzteblatt 2019;
    CrossrefPubMedSearch in Google Scholar
  • 5 Lynen Jansen P, Stallmach A, Lohse AW. et al. [Development of gastrointestinal infectious diseases between 2000 and 2012]. Z Gastroenterol 2014; 52: 549-557
    PubMedSearch in Google Scholar
  • 6 Axelrad JE, Freedberg DE, Whittier S. et al. Impact of Gastrointestinal Panel Implementation on Health Care Utilization and Outcomes. J Clin Microbiol 2019; 57: e01775-18
    CrossrefPubMedSearch in Google Scholar
  • 7 Spina A, Kerr KG, Cormican M. et al. Spectrum of enteropathogens detected by the FilmArray GI Panel in a multicentre study of community-acquired gastroenteritis. Clin Microbiol Infect 2015; 21: 719-728
    CrossrefPubMedSearch in Google Scholar
  • 8 Jansen A, Stark K, Kunkel J. et al. Aetiology of community-acquired, acute gastroenteritis in hospitalised adults: a prospective cohort study. BMC Infect Dis 2008; 8: 143
    CrossrefPubMedSearch in Google Scholar
  • 9 Spandorfer PR, Alessandrini EA, Joffe MD. et al. Oral versus intravenous rehydration of moderately dehydrated children: a randomized, controlled trial. Pediatrics 2005; 115: 295-301
    CrossrefPubMedSearch in Google Scholar
  • 10 Nerandzic MM, Mullane K, Miller MA. et al. Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection. Clin Infect Dis 2012; 55 (Suppl. 02) S121-S126
    CrossrefPubMedSearch in Google Scholar
  • 11 Guery B, Menichetti F, Anttila VJ. et al. Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial. Lancet Infect Dis 2018; 18: 296-307
    CrossrefPubMedSearch in Google Scholar
  • 12 Wilcox MH, Gerding DN, Poxton IR. et al. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. N Engl J Med 2017; 376: 305-317
    CrossrefPubMedSearch in Google Scholar
  • 13 Santoiemma PP, Ison MG, Angarone MP. Newer approaches in diagnosis of diarrhea in immunocompromised patients. Curr Opin Infect Dis 2019; 32: 461-467
    CrossrefPubMedSearch in Google Scholar